May 10, 2017 11:02 am UTC| Business
NIWOT, Colo., May 10, 2017 -- Crocs, Inc. (NASDAQ:CROX) a world leader in innovative casual footwear for men, women and children, today announced its financial results for the first quarter of 2017. These results cover...
May 10, 2017 11:02 am UTC| Business
NIWOT, Colo., May 10, 2017 -- Crocs, Inc. (NASDAQ:CROX) a world leader in innovative casual footwear for men, women and children, today announced its financial results for the first quarter of 2017. These results cover...
May 10, 2017 11:02 am UTC| Business
NIWOT, Colo., May 10, 2017 -- Crocs, Inc. (NASDAQ:CROX) a world leader in innovative casual footwear for men, women and children, today announced its financial results for the first quarter of 2017. These results cover...
May 10, 2017 11:02 am UTC| Business
CAMBRIDGE, Mass., May 10, 2017 -- Vericel Corporation (NASDAQ:VCEL), a leading developer of autologous expanded cell therapies for the treatment of patients with serious diseases and conditions, today announced that the...
May 10, 2017 11:02 am UTC| Business
CAMBRIDGE, Mass., May 10, 2017 -- Vericel Corporation (NASDAQ:VCEL), a leading developer of autologous expanded cell therapies for the treatment of patients with serious diseases and conditions, today announced that the...
May 10, 2017 11:02 am UTC| Business
CAMBRIDGE, Mass., May 10, 2017 -- Vericel Corporation (NASDAQ:VCEL), a leading developer of autologous expanded cell therapies for the treatment of patients with serious diseases and conditions, today announced that the...
May 10, 2017 11:02 am UTC| Business
-- Strong Dose-Dependent Transduction in All Animals Tested Regardless of the Level of Anti-AAV5 Antibodies at Pre-Administration-- -- Data Suggests AAV5 Gene Therapies May be Viable Treatments for Nearly All Patients...